0001127602-19-019957.txt : 20190524
0001127602-19-019957.hdr.sgml : 20190524
20190524200923
ACCESSION NUMBER: 0001127602-19-019957
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190516
FILED AS OF DATE: 20190524
DATE AS OF CHANGE: 20190524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POPS RICHARD F
CENTRAL INDEX KEY: 0001126490
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 19855758
MAIL ADDRESS:
STREET 1: 10555 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-05-16
0001520262
Alkermes plc.
ALKS
0001126490
POPS RICHARD F
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
1
Director and CEO, Alkermes plc
Ordinary Shares
2019-05-16
4
M
0
60000
8.55
A
776433
D
Ordinary Shares
2019-05-16
4
S
0
60000
25.4213
D
716433
D
Ordinary Shares
2019-05-23
4
M
0
50000
8.55
A
766433
D
Ordinary Shares
2019-05-23
4
S
0
50000
24.223
D
716433
D
Employee Stock Option (Right to Buy)
8.55
2019-05-16
4
M
0
60000
0
D
2019-05-26
Ordinary Shares
60000
50000
D
Employee Stock Option (Right to Buy)
8.55
2019-05-23
4
M
0
50000
0
D
2019-05-26
Ordinary Shares
50000
0
D
Late filing due to administrative error.
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.27 to $25.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.02 to $24.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for Richard F. Pops
2019-05-24